[HTML][HTML] Prevention and treatment of venous thromboembolism associated with coronavirus disease 2019 infection: a consensus statement before guidelines

Z Zhai, C Li, Y Chen, G Gerotziafas… - Thrombosis and …, 2020 - thieme-connect.com
Coronavirus disease 2019 (COVID-19) has caused a global pandemic in just a few months,
causing millions infected. Nearly 20% of COVID-19 patients present severe coagulation …

Efficacy and safety of low dose recombinant tissue-type plasminogen activator for the treatment of acute pulmonary thromboembolism: a randomized, multicenter …

C Wang, Z Zhai, Y Yang, Q Wu, Z Cheng, L Liang… - Chest, 2010 - Elsevier
Background Optimal dosing of the recombinant tissue-type plasminogen activator (rt-PA) is
important in treating pulmonary thromboembolism (PTE). The aim of this study was to …

[HTML][HTML] Diffusion capacity abnormalities for carbon monoxide in patients with COVID-19 at 3-month follow-up

…, YL Wan, H Li, I Elalamy, C Li, Z Zhai… - European …, 2021 - Eur Respiratory Soc
Objective To evaluate pulmonary function and clinical symptoms in coronavirus disease 2019
(COVID-19) survivors within 3 months after hospital discharge, and to identify risk factors …

[HTML][HTML] Guidance for the management of patients with vascular disease or cardiovascular risk factors and COVID-19: position paper from VAS-European independent …

…, D Vasic, M Vikkula, P Wennberg, Z Zhai… - Thrombosis and …, 2020 - thieme-connect.com
COVID-19 is also manifested with hypercoagulability, pulmonary intravascular coagulation,
microangiopathy, and venous thromboembolism (VTE) or arterial thrombosis. Predisposing …

[HTML][HTML] Pulmonary embolism incidence and fatality trends in Chinese hospitals from 1997 to 2008: a multicenter registration study

Y Yang, L Liang, Z Zhai, H He, W Xie, X Peng… - PLoS …, 2011 - journals.plos.org
Background There has not been sufficient evidence to support the Asians being less susceptible
to pulmonary embolism (PE) than other ethnicities, because the prevalence of PE/deep …

Trends in hospitalization and in-hospital mortality from VTE, 2007 to 2016, in China

…, W Xie, J Wan, H Chen, Y Ji, Q Yi, X Xu, Y Yang, Z Zhai… - Chest, 2019 - Elsevier
Background VTE has emerged as a major public health problem. However, data on VTE
burden in China are seldom reported. Methods This study collected data on patients with a …

Differences in ventilatory inefficiency between pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension

Z Zhai, K Murphy, H Tighe, C Wang, MR Wilkins… - Chest, 2011 - Elsevier
Background Measures of ventilatory efficiency during cardiopulmonary exercise testing (CPX)
are increasingly being used as prognostic markers in heart failure and pulmonary …

Prevalence and associations of VTE in patients with newly diagnosed lung cancer

Y Zhang, Y Yang, W Chen, L Guo, L Liang, Z Zhai… - Chest, 2014 - Elsevier
BACKGROUND The risk of VTE before anticancer therapy in patients with lung cancer is not
well defined. METHODS A total of 673 hospitalized patients with newly diagnosed lung …

[HTML][HTML] VTE risk profiles and prophylaxis in medical and surgical inpatients: the identification of Chinese hospitalized patients' risk profile for venous …

Z Zhai, Q Kan, W Li, X Qin, J Qu, Y Shi, R Xu, Y Xu… - Chest, 2019 - Elsevier
Background Limited data exist on VTE risk and prophylaxis in Chinese inpatients. The
Identification of Chinese Hospitalized Patients’ Risk Profile for Venous Thromboembolism-2 (…

Evaluation of acute pulmonary embolism and clot burden on CTPA with deep learning

…, X Guo, P Zhang, L Zhang, R Zhang, H Kang, Z Zhai… - European …, 2020 - Springer
Objectives To take advantage of the deep learning algorithms to detect and calculate clot
burden of acute pulmonary embolism (APE) on computed tomographic pulmonary …